↓ Skip to main content

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

Overview of attention for article published in Cancer Immunology, Immunotherapy, February 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
twitter
10 X users
patent
1 patent

Citations

dimensions_citation
120 Dimensions

Readers on

mendeley
167 Mendeley